News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
ReNeuron Release: Preliminary Results for the Year Ended 31 March 2007
July 3, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Application filed in November 2006 to commence initial clinical trial in the US with lead ReN001 stem cell therapy for stroke.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Funding
Backed by Sanofi, Pfizer, Earendil Bags $787M for AI-Driven Biologics Design
March 23, 2026
·
2 min read
·
Tristan Manalac
Parkinson’s disease
Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy
March 23, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Gossamer, BiomX Reveal Hefty Staff Cuts
March 20, 2026
·
39 min read
·
BioSpace Editorial Staff
Policy
Biopharma Could Provide a Haven for Investment as Middle East Conflict Roils Global Markets
March 20, 2026
·
2 min read
·
Annalee Armstrong
